LASER_ENDOUROLOGY_UK_LIMI - Accounts


Company Registration No. SC616520 (Scotland)
LASER ENDOUROLOGY UK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2020
PAGES FOR FILING WITH REGISTRAR
LASER ENDOUROLOGY UK LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
LASER ENDOUROLOGY UK LIMITED
BALANCE SHEET
AS AT
31 MARCH 2020
31 March 2020
- 1 -
2020
Notes
£
£
Fixed assets
Tangible assets
3
2,548
Current assets
Debtors
4
5,619
Cash at bank and in hand
29,712
35,331
Creditors: amounts falling due within one year
5
(25,758)
Net current assets
9,573
Total assets less current liabilities
12,121
Provisions for liabilities
(484)
Net assets
11,637
Capital and reserves
Called up share capital
6
100
Profit and loss reserves
11,537
Total equity
11,637

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 31 March 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 29 June 2020
Dr F  Al Jaafari
Director
Company Registration No. SC616520
LASER ENDOUROLOGY UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2020
- 2 -
1
Accounting policies
Company information

Laser Endourology UK Limited is a private company limited by shares incorporated in Scotland. The registered office is .

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Reporting period

The accounts have been presented for a period longer than one year due to a change in accounting reference date.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for specialist medical services provided in the normal course of business.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computer equipment
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

The carrying value of tangible fixed assets are reviewed for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

LASER ENDOUROLOGY UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2020
1
Accounting policies
(Continued)
- 3 -
1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Debtors

Debtors with no stated interest rate or receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account.

Creditors

Creditors with no stated interest rate and payable within one year are recorded at transaction price.

 

All interest bearing loans and borrowings which are basic financial instruments are initially recorded at the present value of cash payable. After initial recognition they are measured at amortised cost.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

LASER ENDOUROLOGY UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2020
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was 1.

3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 19 December 2018
-
Additions
3,453
At 31 March 2020
3,453
Depreciation and impairment
At 19 December 2018
-
Depreciation charged in the period
905
At 31 March 2020
905
Carrying amount
At 31 March 2020
2,548
4
Debtors
2020
Amounts falling due within one year:
£
Trade debtors
3,530
Other debtors
2,089
5,619
LASER ENDOUROLOGY UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 MARCH 2020
- 5 -
5
Creditors: amounts falling due within one year
2020
£
Taxation and social security
20,930
Other creditors
4,828
25,758
6
Called up share capital
2020
£
Ordinary share capital
Issued and fully paid
45 A ordinary shares of £1 each
45
45 B ordinary shares of £1 each
45
5 C ordinary shares of £1 each
5
5 D ordinary shares of £1 each
5
100

On incorporation 45 ordinary £1 shares were allotted at par. These shares were redesignated to A ordinary shares on 26 March 2019. On the same date 45 B ordinary £1 shares, 5 C ordinary £1 shares and 5 D ordinary £1 shares were allotted at par.

7
Related party transactions

The director is of the opinion that all related party transactions are conducted under normal market conditions and on an arm's length basis and therefore do not need to be disclosed under FRS 102 section 1A appendix C.

2020-03-312018-12-19false29 June 2020CCH SoftwareCCH Accounts Production 2020.100No description of principal activityDr F Al JaafariSC6165202018-12-192020-03-31SC6165202020-03-31SC616520core:OtherPropertyPlantEquipment2020-03-31SC616520core:CurrentFinancialInstrumentscore:WithinOneYear2020-03-31SC616520core:CurrentFinancialInstruments2020-03-31SC616520core:ShareCapital2020-03-31SC616520core:RetainedEarningsAccumulatedLosses2020-03-31SC616520core:ShareCapitalOrdinaryShares2020-03-31SC616520bus:Director12018-12-192020-03-31SC616520core:ComputerEquipment2018-12-192020-03-31SC616520core:OtherPropertyPlantEquipment2018-12-192020-03-31SC616520core:WithinOneYear2020-03-31SC616520bus:PrivateLimitedCompanyLtd2018-12-192020-03-31SC616520bus:SmallCompaniesRegimeForAccounts2018-12-192020-03-31SC616520bus:FRS1022018-12-192020-03-31SC616520bus:AuditExemptWithAccountantsReport2018-12-192020-03-31SC616520bus:FullAccounts2018-12-192020-03-31xbrli:purexbrli:sharesiso4217:GBP